Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus STLD Q1 2026 Earnings EPS Misses Estimates but Shares Rally on Operational Strengths YDKG Q4 2012 Earnings EPS Misses Estimates Amidst Uncertain Operating Environment BWIN Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Progress TGT Q1 2026 Earnings EPS of 171 Highlights Resilient Operations Amid Modest Stock Decline Altimmune Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Development